Biomaterials Market in Brazil Will Reach USD 5.18 billion

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
82
Biomaterials Market in Brazil Will Reach USD 5.18 billion in 2022: Zion Market Research

Sarasota, FL, May 22, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Biomaterials Market (Cardiovascular Biomaterials, Orthopedic Biomaterials, Wound Care Biomaterials, Urological Biomaterials Plastic Surgery Biomaterials, and Gastrointestinal Biomaterials)  by Materials (Ceramics, Metals and Polymers) for Drug Delivery, Dental Products, Surgical Appliances & Supplies, General Surgery, Electromedical Equipment and Other Applications: Brazil Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022” . According to the report, demand for  Brazil biomaterials market  in was valued at over USD1.89 billion in 2016, is expected to reach above USD 5.18 billion in 2022 and is anticipated to grow at a CAGR of slightly above 18.30% between 2017 and 2022.

Biomaterials are synthetic, natural, solid or liquid, which are mainly used in medical devices, biological systems. In recent times, biomaterials are also used to grow cells in culture, processing biomolecular in biotechnology, bio-inert to assay for blood proteins in the clinical laboratory, for fertility regulation implants in cattle, in diagnostic gene arrays. Biomaterials are also used in the aquaculture of oysters and for investigational cell-silicon "biochips." 

Browse through 6 Market Tables and 22 Figures spread through 110 Pages and in-depth TOC on “Brazil Biomaterials Market: By Type, Product, Material, Application, Size, Share, Growth, Analysis, Segment and Forecast 2016 – 2022”.

Request Free Sample copy of Global Biomaterials Market Report @ https://www.zionmarketresearch.com/sample/bio...als-market

Rising prevalence of diverse diseases has led to huge growth in the healthcare sector. This factor is expected to fuel the growth of the biomaterials market in the coming years. Growing aging population in Brazil is likely to positively impact on the growth of the biomaterials market in the forecast period. Biomaterials are used in various applications such as contact lens, dental, gene transfer, skin repair and in drug delivery system among others. This factor may stimulate the biomaterial market growth in the upcoming years. Hectic lifestyle along with increasing demand for western food has led to high cardiovascular diseases. Hence, rising cardiovascular disease may trigger the growth of the biomaterials market in the forecast period. Nevertheless, ongoing research for debio-inert materials may provide ample opportunities to the biomaterials market in the forecast period. Moreover, tremendously expanding healthcare sector in Brazil and growing medical tourism may foster the market in the coming years.

The biomaterials market can be segmented into products which include cardiovascular biomaterials, orthopedic biomaterials, wound care biomaterials, urological biomaterials plastic surgery biomaterials and gastrointestinal biomaterials. Cardiovascular biomaterials can be further sub-segmented into vascular access devices, cardiac stents, artificial heart valves, peripheral vascular grafts, cardiac pacemakers and implantable cardioverter defibrillators. Orthopedic biomaterials consist of implantable cardioverter defibrillators, trauma orthopedic biomaterials, trauma orthopedic biomaterials, bone cement, ortho biologics biomaterials, and reconstructive biomaterials. Orthopedic biomaterials comprise high product penetration. Therefore, orthopedic biomaterials will specter huge demand in the coming years. Moreover, owing to unhealthy lifestyle there has been tremendous growth in the cardiovascular diseases which has led to the high usage of cardiovascular biomaterials. The materials mainly used in biomaterials are ceramics, metals, and polymers. Biomaterials possess diverse applications, some of which includes drug delivery, dental products, surgical appliances & supplies, general surgery, electromedical equipment and other applications.

Browse the full " Biomaterials Market (Cardiovascular Biomaterials, Orthopedic Biomaterials, Wound Care Biomaterials, Urological Biomaterials Plastic Surgery Biomaterials and Gastrointestinal Biomaterials)  by Materials (Ceramics, Metals and Polymers) for Drug Delivery, Dental Products, Surgical Appliances & Supplies, General Surgery, Electromedical Equipment and Other Applications: Brazil Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022 " report at  https://www.zionmarketresearch.com/report/bio...als-market

There has been the sharp rise in the healthcare industry in Brazil owing to low healthcare cost. Brazil stands as the fifth largest country area wise and in population. The healthcare sector has undergone rapid transformation owing to the new business paradigm in Brazilian healthcare market. This factor is expected to trigger the growth of biomaterials market in this region in the upcoming years. An increasing number of life expectancy among the aging population may boost the biomaterials market in the forecast period. Moreover, Brazil is considered as the most favorable destination for medical tourism owing to its superior medical facilities, high-quality services, and low cost for treatment. This aspect is likely to bolster the growth of the biomaterial market.

Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/bi...als-market

Allergan Inc., Artimplant Ab, Alphatec Spine Inc, Biomet Inc., Synthes Inc., Integra Life Sciences Holdings Corporation, Wright Medical Group, Inc., Stryker Corporation, Baxter International Inc. and Boston Scientific Corporation are some of the major players operating in the biomaterials market in Brazil. Due to various favorable government regulations many of the major companies are pulling towards Brazil.

Directly Purchase a copy of report with TOC @ https://www.zionmarketresearch.com/buynow/su/...als-market

This report segments Brazil biomaterials market as follows: 

Biomaterials Market: Product Analysis

  • Cardiovascular biomaterials
  • Orthopedic biomaterials
  • Wound care biomaterials
  • Urological biomaterials
  • Plastic surgery biomaterials
  • Gastrointestinal biomaterials

Biomaterials Market: Material Analysis

  • Ceramics
  • Metals
  • Polymers

Biomaterials Market: Applications Analysis

  • Drug Delivery
  • Dental Products
  • Surgical Appliances & Supplies
  • General Surgery
  • Electromedical Equipment
  • Others

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research

Follow Us Twitter: https://twitter.com/zion_research

Contact Us: Joel John 4283, Express Lane, Suite 634-143, Sarasota, Florida 34249, United States Tel: +49-322 210 92714 USA/Canada Toll-Free No.1-855-465-4651 Email: sales@zionmarketresearch.com Website: https://www.zionmarketresearch.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Peptide Therapy Rules Change: Gameday Ups the Ante

Updated Category News Views 110

Gameday Men's Health: Leading the Safe Peptide Charge Finally, we got some regulatory sanity stepping up to the plate with peptides. You see, the FDA's new interim policy is letting state-licensed compounding pharmacies work their magic with peptides, but only under strict medical watch. And Gameday Men's Health sure ain't wasting any time setting up shop in this fresh...

Continue Reading
Fidelis Care Opens $120K Workforce Grants for Aid

Updated Category News Views 112

Fidelis Care Steps Up Workforce Engagement Fidelis Care's latest move introduces a fresh shot at tackling two birds with one stone—economic and health stability for Medicaid members. The Workforce Pathways to Health and Economic Mobility grants present up to $120,000 in support for New Yorkers, an attempt aimed squarely at reducing the vicious cycle that traps many in...

Continue Reading
Chip Earnings Fuel Market Gains Amid Volatility Dip

Updated Category News Views 56

Tech Earnings Drive Market Resilience Amid a climate of economic uncertainty, it's refreshing to see semiconductor and tech earnings offering a little backbone to the market. This week, the S&P 500 climbed 1.51%, while the Nasdaq Composite jumped 1.98% over three sessions. It's like watching Rocky get up off the mat—those indices pushing higher when it seemed like they...

Continue Reading
Read/Write Labs Tackles Brain-Tech Fusion Ambitions

Updated Category News Views 88

Buck up, investors! There's a new player on the field marrying AI and neuroscience with some serious firepower and a respectable roster. Read/Write Labs—what you might've known yesterday as Dandelion Science—has kicked off under a fresh banner, amping up efforts to decode and recode our noggin's electrical orchestra. And with the likes of Jim DiCarlo, Dan Yamins, and...

Continue Reading
Fannie Mae Q3 2026 Earnings Surpass Expectations

Updated Category News Views 84

An Upward Trend in Fannie Mae's Financials Hold onto your hats—Fannie Mae's swinging into action with hefty third-quarter numbers that'd make most firms drool. The latest figures, disclosed in their 10-Q filing, boast a net income of $4.2 billion for Q3 2026. You heard me right, billion! Now, to a market vet, these aren't digits to scoff at. And as the economy keeps...

Continue Reading
Aktia Bank: Steady Ratings, Focused Expansion in Europe

Updated Category News Views 123

Aktia's Ratings Get a Boost In the world of financial minutiae, it was S&P Global Ratings that took the stage, buzzing about Aktia Bank Plc. The bank just had its ratings held steady with an outlook lift from negative to stable. That's like someone throwing you a life jacket when you're treading water; significant if you're trying to stay afloat, not so much if you've got...

Continue Reading
ESENTIA Lifts EBITDA, Reduces Debt, Eyes Expansion

Updated Category News Views 38

ESENTIA Flexes Financial Muscles: What's the Deal? Walk with me through the gritty world of financials, and you’ll see that ESENTIA’s latest figures are a mixed bag with a tantalizing upside. We're talking about adjusted EBITDA ticking up to a cool $86 million in the third quarter of '26, a 1.3% lift from last year. Not too shabby, eh? Especially when you're grappling...

Continue Reading
VeriSilicon's GLTiny: Game-Changer for Wearable Tech

Updated Category News Views 45

Revolutionizing Wearable Graphics with GLTiny There's a fresh breeze blowing through the world of wearable tech, and VeriSilicon's GLTiny seems to be at the heart of it. When the silicon giant out of Shanghai tossed GLTiny into the mix, it wasn't just throwing another chip on the barbie. Oh no, this is a real pivot towards juicing up those smart gadgets strapped to your...

Continue Reading
Ballard’s HPU Agile-H Poised to Transform Portable Energy

Updated Category News Views 76

Another Step Forward with Hydrogen Ballard's got another ace up its sleeve with the HPU Agile-H. Now here’s the kicker—everyone’s scrambling for cleaner, more portable energy solutions, and Ballard’s stepped up. Born from their acquisition of GeoPura, this lightweight hydrogen powerhouse is engineered for those spots rudely ignored by the grid. Place your bets on...

Continue Reading
Replay Sports Cards Nets STAR Award for Innovation

Updated Category News Views 82

A New Era for Franchise Onboarding Just when you think the sports card world couldn't get any more niche, along comes Replay Sports Cards thumping its chest with some serious innovation. This Charlotte-based franchise just snagged the Franchise Innovation Award from Franchise Update Media. Yep, they're the only ones getting tips of the hat for the Most Innovative...

Continue Reading

Top 5 Most Recently Viewed Articles

Sollis Health Welcomes Katy Marshall as Chief Growth Officer

Updated Category News Views 511

Sollis Health Welcomes Katy Marshall as Chief Growth Officer The leading concierge medical provider has appointed Katy Marshall as Chief Growth Officer. With her extensive background in driving growth for consumer and healthcare brands, she will guide the company's marketing, sales, and product strategies. Experienced Leadership Katy brings a wealth of experience to...

Continue Reading
Kulicke & Soffa Delivers Strong Q4 Performance Highlights

Updated Category News Views 153

Strong Financial Performance in Q4 Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) reported impressive financial results for the fourth quarter, showcasing resilience and growth in a challenging market. The company achieved a net revenue of $177.6 million, reflecting its ongoing commitment to innovation and operational efficiency. Lester Wong, the Interim Chief...

Continue Reading
Unlocking Dividend Income: Strategies for Salesforce Investors

Updated Category News Views 85

Understanding Salesforce's Dividend Potential Salesforce, Inc. (NYSE: CRM) is a leading company known for its innovative cloud-based solutions. With its upcoming fourth-quarter financial results, many investors are curious about how to maximize their returns, particularly through dividends. This approach can be an excellent way to create a significant income stream while...

Continue Reading
Investigation Launched into Sage Therapeutics' Recent Drug Trials

Updated Category News Views 93

Introducing Sage Therapeutics Sage Therapeutics, Inc. (NASDAQ: SAGE) is a biopharmaceutical company dedicated to developing innovative therapies aimed at enhancing brain health. However, recent events have raised serious concerns among investors, prompting an investigation into possible violations of federal securities laws. Stock Price Affected by Recent Events FDA...

Continue Reading
Genius Group Investors Can Pursue Class Action for Losses

Updated Category News Views 208

Genius Group Limited Faces Class Action Lawsuit Genius Group Limited, recognized by its ticker symbol GNUS, is currently embroiled in a class action lawsuit aimed at addressing significant investor losses. This legal action comes as a response to alleged stock market misconduct by certain trading firms. Investors Encouraged to Take Action The law firm Bronstein, Gewirtz &...

Continue Reading